Hannah Roggenkamp
she/her/hers
Assistant ProfessorDownloadHi-Res Photo
Cards
Appointments
Psychiatry
Primary
Contact Info
About
Titles
Assistant Professor
Appointments
Education & Training
- MD
- Sidney Kimmel Medical College (2012)
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of Hannah Roggenkamp's published research.
Publications Timeline
A big-picture view of Hannah Roggenkamp's research output by year.
Ilse Wiechers, MD, MPP, MHS
Joel Gelernter, MD
8Publications
74Citations
Publications
2022
Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder
Oslin DW, Lynch KG, Shih MC, Ingram EP, Wray LO, Chapman SR, Kranzler HR, Gelernter J, Pyne JM, Stone A, DuVall SL, Lehmann LS, Thase ME, Aslam M, Batki S, Bjork J, Blow F, Brenner L, Chen P, Desai S, Dieperink E, Fears S, Fuller M, Goodman C, Graham D, Haas G, Hamner M, Helstrom A, Hurley R, Icardi M, Jurjus G, Kilbourne A, Kreyenbuhl J, Lache D, Lieske S, Lynch J, Meyer L, Montalvo C, Muralidhar S, Ostacher M, Paschall G, Pfeiffer P, Prieto S, Przygodzki R, Ranganathan M, Rodriguez-Suarez M, Roggenkamp H, Schichman S, Schneeweis J, Simonetti J, Steinhauer S, Suppes T, Umbert M, Vassy J, Voora D, Wiechers I, Wood A. Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder. JAMA 2022, 328: 151-161. PMID: 35819423, PMCID: PMC9277497, DOI: 10.1001/jama.2022.9805.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsMajor depressive disorderPatient Health Questionnaire-9Usual care groupUsual carePharmacogenomic testingDrug-gene interactionsRemission rateMedication selectionCare groupDepressive disorderVeterans Affairs Medical CenterActive substance use disorderCo-primary outcomesPrescription of medicationsBetter clinical outcomesProportion of prescriptionsRemission of symptomsSubstance use disordersEligible patientsWeek 24Effective antidepressantSingle antidepressantClinical outcomesInitial treatmentQuestionnaire-9
2019
Healthcare cost reduction and psychiatric symptom improvement in posttraumatic stress disorder patients treated with intensive short-term dynamic psychotherapy
Roggenkamp, H, Abbass, A, Town, J, Kisely, S, Johansson, R. Healthcare cost reduction and psychiatric symptom improvement in posttraumatic stress disorder patients treated with intensive short-term dynamic psychotherapy. European Journal of Trauma and Dissociation, 2019, article 100122. DOI:10.1016/j.ejtd.2019.100122Peer-Reviewed Original ResearchArmy sexual harassment/sexual assault response & prevention program (SHARP) tiger team: a model to inform prevention
Skopp, N, Roggenkamp, H, Hoyt, T, Major, H, Williams, T. Army sexual harassment/sexual assault response & prevention program (SHARP) tiger team: a model to inform prevention. Military Behavioral Health, 2019, 8: 61-73. DOI:10.1080/21635781.2019.1670763Peer-Reviewed Original Research
2017
Tattoos as a window to the psyche: How talking about skin art can inform psychiatric practice.
Roggenkamp H, Nicholls A, Pierre JM. Tattoos as a window to the psyche: How talking about skin art can inform psychiatric practice. World J Psychiatry 2017, 7: 148-158. PMID: 29043152, DOI: 10.5498/wjp.v7.i3.148.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsFatigue -- but not mTBI history, PTSD, or sleep quality -- directly contributes to prospective memory performance in Iraq and Afghanistan era Veterans
Rau, H, Hendrickson, R, Roggenkamp, H, Peterson, S, Parmenter, B, Cook, D, Peskind, E, Pagulayan, K. Fatigue -- but not mTBI history, PTSD, or sleep quality -- directly contributes to prospective memory performance in Iraq and Afghanistan era Veterans. The Clinical Neuropsychologist, 2017, DOI: 10.1080/13854046.2017.1381277Peer-Reviewed Original Research
2014
Development and evaluation of the belief acceptance scal
Wintering, N, Roggenkamp, H, Moss, A, Shea, J, Waldman, M, Newberg, A. Development and evaluation of the belief acceptance scale. Journal of Beliefs and Values: Studies in Religion and Education, 2014, 35 (1): 48-60. https://doi.org/10.1080/13617672.2014.884850Peer-Reviewed Original Research
2012
Effects of an 8-week meditation program on mood and anxiety in patients with memory loss.
Moss AS, Wintering N, Roggenkamp H, Khalsa DS, Waldman MR, Monti D, Newberg AB. Effects of an 8-week meditation program on mood and anxiety in patients with memory loss. J Altern Complement Med 2012, 18: 48-53. PMID: 22268968, DOI: 10.1089/acm.2011.0051.Peer-Reviewed Original Research
2010
Meditation effects on cognitive function and cerebral blood flow in subjects with memory loss: a preliminary study.
Newberg AB, Wintering N, Khalsa DS, Roggenkamp H, Waldman MR. Meditation effects on cognitive function and cerebral blood flow in subjects with memory loss: a preliminary study. J Alzheimers Dis 2010, 20: 517-26. PMID: 20164557, DOI: 10.3233/JAD-2010-1391.Peer-Reviewed Original Research